NFKB1 and cancer: However, as demonstrated above, the paracrine secretion of senescent Spalax cells, which triggers the senescence program in cancer cells, simultaneously reduces the level of DNA damage that, in turn, could inhibit NF-κB activation and the inflammatory response in these cells.